Charles River Laboratories International (CRL) Competitors $161.55 +7.01 (+4.54%) Closing price 03:59 PM EasternExtended Trading$163.00 +1.45 (+0.90%) As of 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. ICLR, TECH, IQV, MTD, WAT, ILMN, BIO, BRKR, PACB, and HBIOShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Icon (ICLR), Bio-Techne (TECH), IQVIA (IQV), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), and Harvard Bioscience (HBIO). Charles River Laboratories International vs. Its Competitors Icon Bio-Techne IQVIA Mettler-Toledo International Waters Illumina Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Icon (NASDAQ:ICLR) and Charles River Laboratories International (NYSE:CRL) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation. Which has higher earnings and valuation, ICLR or CRL? Icon has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.71$791.47M$9.7218.09Charles River Laboratories International$4.05B1.96$22.20M-$1.33-121.47 Do analysts prefer ICLR or CRL? Icon currently has a consensus price target of $218.38, indicating a potential upside of 24.20%. Charles River Laboratories International has a consensus price target of $175.69, indicating a potential upside of 8.75%. Given Icon's stronger consensus rating and higher possible upside, equities analysts clearly believe Icon is more favorable than Charles River Laboratories International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 6 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 2.75Charles River Laboratories International 1 Sell rating(s) 9 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.27 Is ICLR or CRL more profitable? Icon has a net margin of 9.82% compared to Charles River Laboratories International's net margin of -1.69%. Charles River Laboratories International's return on equity of 15.74% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.82% 10.95% 6.23% Charles River Laboratories International -1.69%15.74%7.09% Do institutionals & insiders believe in ICLR or CRL? 95.6% of Icon shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 44.0% of Icon shares are owned by company insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, ICLR or CRL? Icon has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Does the media refer more to ICLR or CRL? In the previous week, Charles River Laboratories International had 4 more articles in the media than Icon. MarketBeat recorded 14 mentions for Charles River Laboratories International and 10 mentions for Icon. Charles River Laboratories International's average media sentiment score of 1.12 beat Icon's score of 0.02 indicating that Charles River Laboratories International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Charles River Laboratories International 10 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryIcon beats Charles River Laboratories International on 10 of the 17 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$7.61B$7.70B$5.76B$20.94BDividend YieldN/A2.71%4.41%3.58%P/E Ratio-121.4778.4731.1029.13Price / Sales1.9649.18436.1253.05Price / Cash7.1224.6737.7323.54Price / Book2.3724.799.535.45Net Income$22.20M$243.33M$3.26B$992.10M7 Day Performance3.12%1.08%2.11%2.62%1 Month Performance-1.03%0.80%5.12%2.51%1 Year Performance-19.72%13.93%31.25%12.94% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.0423 of 5 stars$161.55+4.5%$175.69+8.8%-24.3%$7.61B$4.05B-121.4720,100News CoveragePositive NewsInsider TradeICLRIcon4.2894 of 5 stars$178.56+1.5%$219.54+22.9%-45.6%$14.42B$8.28B18.3741,900Analyst ForecastTECHBio-Techne4.8158 of 5 stars$53.29-0.6%$69.42+30.3%-25.7%$8.35B$1.22B115.853,100Positive NewsDividend AnnouncementAnalyst UpgradeIQVIQVIA4.8965 of 5 stars$192.58+0.8%$228.62+18.7%-25.0%$32.74B$15.41B27.8788,000Short Interest ↓MTDMettler-Toledo International4.028 of 5 stars$1,315.45+0.2%$1,288.89-2.0%-10.8%$27.10B$3.87B33.3117,300Positive NewsAnalyst ForecastInsider TradeWATWaters4.8317 of 5 stars$289.15-0.8%$378.73+31.0%-13.8%$17.21B$3.05B26.077,600Trending NewsILMNIllumina4.6582 of 5 stars$100.53+0.4%$124.58+23.9%-25.1%$15.45B$4.37B12.739,030Positive NewsBIOBio-Rad Laboratories4.5754 of 5 stars$284.39-0.4%$333.50+17.3%-10.1%$7.70B$2.57B24.247,700Positive NewsBRKRBruker4.9689 of 5 stars$34.24+2.1%$51.30+49.8%-48.0%$5.19B$3.37B65.8511,396PACBPacific Biosciences of California2.3034 of 5 stars$1.33+1.5%$1.90+42.9%-18.4%$399.49M$154.01M-0.58730HBIOHarvard Bioscience3.8575 of 5 stars$0.50-4.6%$3.00+494.4%-83.7%$22.48M$88.75M-0.39490Gap Up Related Companies and Tools Related Companies Icon Alternatives Bio-Techne Alternatives IQVIA Alternatives Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access